News + Filings Transactions Holdings
All 13F 13D/G Other
|
Thomas, McNerney & Partners II L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/25/2022 |
4/A
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on Clarus Therapeutics Holdings, Inc.
Txns:
| Sold 1,663,126 shares
@ $2.53, valued at
$4.2M
Sold 2,061,685 shares
@ $2.53, valued at
$5.2M
Sold 5,722 shares
@ $2.53, valued at
$14.5k
Sold 13,630 shares
@ $2.53, valued at
$34.5k
Sold 1,164 shares
@ $2.53, valued at
$2.9k
Sold 7,585 shares
@ $2.53, valued at
$19.2k
|
|
04/21/2022 |
4
| THOMAS MCNERNEY & PARTNERS LP (10% Owner) has filed a Form 4 on CLARUS THERAPEUTICS INC
Txns:
| Sold 1,663,126 shares
@ $2.53, valued at
$4.2M
Sold 2,061,685 shares
@ $2.53, valued at
$5.2M
Sold 5,722 shares
@ $2.53, valued at
$14.5k
Sold 13,630 shares
@ $2.53, valued at
$34.5k
Sold 1,164 shares
@ $2.53, valued at
$2.9k
Sold 7,585 shares
@ $2.53, valued at
$19.2k
|
|
09/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/22/2019 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC
Txns:
| Converted 6,802,834 shares
@ $2.389, valued at
$16.3M
Converted 24,125 shares
@ $2.389, valued at
$57.6k
Converted 71,075 shares
@ $2.389, valued at
$169.8k
Converted 3,906,315 shares
@ $2.389, valued at
$9.3M
Converted 13,881 shares
@ $2.389, valued at
$33.2k
Converted 40,772 shares
@ $2.389, valued at
$97.4k
Disposed/sold 12,300,186 shares
@ $2.45, valued at
$30.1M
Disposed/sold 43,944 shares
@ $2.45, valued at
$107.7k
Disposed/sold 119,872 shares
@ $2.45, valued at
$293.7k
Converted 94,182 convertible preferred
@ $0 Converted 334 convertible preferred
@ $0 |
|
04/22/2019 |
SC 13D/A
| Thomas, McNerney & Partners II L.P. reports a 0% stake in CAS Medical Systems, Inc. |
02/13/2019 |
SC 13D/A
| Thomas, McNerney & Partners II L.P. reports a 31.3% stake in CAS Medical Systems, Inc. |
03/26/2018 |
SC 13G/A
| Thomas, McNerney & Partners II L.P. has filed a Schedule 13D for Invitae Corporation |
02/15/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/16/2016 |
SC 13G
| Invitae Corp reports a 11.7% stake in Invitae Corporation |
05/07/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Unknown transaction of 4,835,731 shares
@ $0 |
|
02/18/2015 |
4
| AGUIAR ERIC (10% Owner) has filed a Form 4 on Invitae Corp
Txns:
| Converted 3,732,460 shares
@ $0 Converted 11,363,636 preferred shares
@ $0 Converted 5,263,155 preferred shares
@ $0 Converted 3,267,973 preferred shares
@ $0 Converted 2,500,000 preferred shares
@ $0 |
|
02/13/2015 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on CAS MEDICAL SYSTEMS INC
Txns:
| Bought 1,591,037 shares
@ $1.3, valued at
$2.1M
Bought 8,025 shares
@ $1.3, valued at
$10.4k
Bought 5,938 shares
@ $1.3, valued at
$7.7k
|
|
01/30/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Sold 730,000 shares
@ $53.11, valued at
$38.8M
|
|
01/12/2015 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Disposed/sold 24,008 shares
@ $51.574, valued at
$1.2M
Exercised 59,277 warrants
@ $3.879, valued at
$229.9k
Exercised 169,630 warrants
@ $3.879, valued at
$658k
Exercised 90,228 warrants
@ $3.879, valued at
$350k
|
|
10/14/2014 |
4
| Thomas, McNerney & Partners II, LLC (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Disposed/sold 9,771 shares
@ $23.885, valued at
$233.4k
Exercised 60,151 options to buy
@ $3.879, valued at
$233.3k
|
|
09/19/2014 |
4/A
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Disposed/sold 12,400 shares
@ $20598, valued at
$255.4M
Exercised 65,839 warrants
@ $3.879, valued at
$255.4k
|
|
09/09/2014 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Sold 12,400 shares
@ $20.598, valued at
$255.4k
Exercised (in-or-at-the-money) 65,839 warrants
@ $3.879, valued at
$255.4k
|
|
02/12/2014 |
4
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Auspex Pharmaceuticals, Inc.
Txns:
| Converted 5,083,451 shares
@ $0 Bought 83,334 shares
@ $12, valued at
$1M
Converted 2,289,771 convertible preferred
@ $0 Converted 7,552,207 convertible preferred
@ $0 Converted 11,915,254 convertible preferred
@ $0 Converted 1,118,298 convertible preferred
@ $0 Converted 296,281 options to buy
@ $0.862, valued at
$255.4k
Converted 65,839 warrants
@ $3.879, valued at
$255.4k
Converted 270,687 options to buy
@ $0.862, valued at
$233.3k
Converted 60,151 warrants
@ $3.879, valued at
$233.3k
Converted 266,750 options to buy
@ $0.862, valued at
$229.9k
|
|
07/17/2013 |
4/A
| Thomas, McNerney & Partners II L.P. (10% Owner) has filed a Form 4 on Ocera Therapeutics, Inc.
Txns:
| Acquired 687,176 shares
@ $6, valued at
$4.1M
Acquired 1,751,393 shares
@ $6, valued at
$10.5M
Granted 25,000 options to buy
@ $4, valued at
$100k
Granted 31,835 options to buy
@ $4.24, valued at
$135k
Granted 100,000 options to buy
@ $0.11, valued at
$11k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 25,000 options to buy
@ $0.22, valued at
$5.5k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
Granted 161,855 warrants
@ $0.08, valued at
$12.9k
|
|
01/14/2013 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
09/06/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
09/01/2011 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
06/20/2011 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership |
11/30/2010 |
4
| THOMAS MCNERNEY & PARTNERS LP (See Footnote (10)) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Converted 490,502 shares
@ $0 Converted 392,585 shares
@ $0 Bought 524,229 shares
@ $4, valued at
$2.1M
Converted 5,123 shares
@ $0 Converted 4,101 shares
@ $0 Bought 5,476 shares
@ $4, valued at
$21.9k
Converted 1,840 shares
@ $0 Converted 1,473 shares
@ $0 Bought 1,967 shares
@ $4, valued at
$7.9k
Converted 4,905,024 convertible preferred
@ $0 Converted 392,585 convertible notes
@ $0 |
|
11/29/2010 |
4
| THOMAS MCNERNEY & PARTNERS LP (See Footnote (10)) has filed a Form 4 on ZOGENIX, INC.
Txns:
| Converted 1,152,780 shares
@ $0 Converted 207,159 shares
@ $0 Converted 129,855 shares
@ $0 Bought 173,399 shares
@ $4, valued at
$693.6k
Converted 42,840 shares
@ $0 Converted 7,697 shares
@ $0 Converted 2,379 shares
@ $0 Bought 3,178 shares
@ $4, valued at
$12.7k
Converted 4,380 shares
@ $0 Converted 786 shares
@ $0 Converted 484 shares
@ $0 |
|
11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
11/22/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|